Order Article Reprints

Ferreira Junior NC, dos Santos Pereira M, Francis N, Ramirez P, Martorell P, González-Lizarraga F, Figadère B, Chehin R, Del Bel E, Raisman-Vozari R, et al. The Chemically-Modified Tetracycline COL-3 and Its Parent Compound Doxycycline Prevent Microglial Inflammatory Responses by Reducing Glucose-Mediated Oxidative Stress. Cells. 2021; 10(8):2163. https://doi.org/10.3390/cells10082163

Ferreira Junior, Nilson Carlos, Maurício dos Santos Pereira, Nour Francis, Paola Ramirez, Paula Martorell, Florencia González-Lizarraga, Bruno Figadère, Rosana Chehin, Elaine Del Bel, Rita Raisman-Vozari, and et al. 2021. "The Chemically-Modified Tetracycline COL-3 and Its Parent Compound Doxycycline Prevent Microglial Inflammatory Responses by Reducing Glucose-Mediated Oxidative Stress" Cells 10, no. 8: 2163. https://doi.org/10.3390/cells10082163

Ferreira Junior, N. C., dos Santos Pereira, M., Francis, N., Ramirez, P., Martorell, P., González-Lizarraga, F., Figadère, B., Chehin, R., Del Bel, E., Raisman-Vozari, R., & Michel, P. P. (2021). The Chemically-Modified Tetracycline COL-3 and Its Parent Compound Doxycycline Prevent Microglial Inflammatory Responses by Reducing Glucose-Mediated Oxidative Stress. Cells, 10(8), 2163. https://doi.org/10.3390/cells10082163